Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Alector, Inc. (ALEC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/10/2023 |
SC 13G/A
| FIL Ltd reports a 14.5% stake in ALECTOR INC |
| 10/03/2023 |
4
| Romano Gary (Chief Medical Officer) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 108,000 shares
@ $0
Granted 36,000 options to buy
@ $6.48, valued at
$233.3k
|
|
| 10/03/2023 |
4
| GRASSO MARC (CFO) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 123,000 shares
@ $0
Granted 41,000 options to buy
@ $6.48, valued at
$265.7k
|
|
| 10/03/2023 |
4
| Kenkare-Mitra Sara (President and Head of R&D) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 163,600 shares
@ $0
Granted 54,500 options to buy
@ $6.48, valued at
$353.2k
|
|
| 10/03/2023 |
4
| Rosenthal Arnon (CEO) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 397,600 shares
@ $0
Granted 132,500 options to buy
@ $6.48, valued at
$858.6k
|
|
| 08/24/2023 |
4
| MCGUIRE TERRANCE (10% Owner) has filed a Form 4 on Alector, Inc.|
Txns:
| Disposed of 500,000 shares
@ $0
Acquired 6,429 shares
@ $0
Acquired 98,533 shares
@ $0
Disposed of 98,533 shares
@ $0
Acquired 13,133 shares
@ $0 |
|
| 08/24/2023 |
4
| Polaris Venture Management Co. VI, L.L.C. (10% Owner) has filed a Form 4 on Alector, Inc.|
Txns:
| Disposed of 500,000 shares
@ $0
Acquired 98,533 shares
@ $0
Disposed of 98,533 shares
@ $0 |
|
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 06/05/2023 |
4
| Kenkare-Mitra Sara (President and Head of R&D) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 4,092 shares
@ $6.9037, valued at
$28.2k
|
|
| 06/05/2023 |
4
| GRASSO MARC (CFO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 1,050 shares
@ $6.9037, valued at
$7.2k
|
|
| 06/05/2023 |
4
| Romano Gary (Chief Medical Officer) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 2,617 shares
@ $6.9037, valued at
$18.1k
|
|
| 06/05/2023 |
4
| Rosenthal Arnon (CEO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 5,255 shares
@ $6.9037, valued at
$36.3k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/08/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 05/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/27/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/03/2023 |
4
| Romano Gary (Chief Medical Officer) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 2,145 shares
@ $8.7082, valued at
$18.7k
Sold 3,238 shares
@ $8.3179, valued at
$26.9k
|
|
| 03/03/2023 |
4
| Kenkare-Mitra Sara (President and Head of R&D) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 10,124 shares
@ $8.3185, valued at
$84.2k
|
|
| 03/03/2023 |
4
| GRASSO MARC (CFO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 1,291 shares
@ $8.3184, valued at
$10.7k
|
|
| 03/03/2023 |
4
| Rosenthal Arnon (CEO) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 5,849 shares
@ $8.3178, valued at
$48.7k
|
|
| 02/28/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 02/28/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|
|
|